You have 9 free searches left this month | for more free features.

Sclerosis

Showing 1 - 25 of 5,161

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Inflammatory Disease in Multiple Sclerosis

Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Multiple Sclerosis
  • Cerebrospinal and Blood Serum Semaphorin 4A Levels
  • Portland, Oregon
    Providence St. Vincent Medical Center
May 19, 2022

Relapsing Remitting Multiple Sclerosis Trial in Glasgow (Clinical assessment)

Enrolling by invitation
  • Relapsing Remitting Multiple Sclerosis
  • Clinical assessment
  • Glasgow, United Kingdom
    Clinical Research Facility
Jul 20, 2022

Multiple Sclerosis Trial in Izmir (Exergaming)

Recruiting
  • Multiple Sclerosis
  • Exergaming
  • İzmir, Turkey
    Dokuz Eylul University
Jun 10, 2022

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

Recruiting
  • Multiple Sclerosis
  • +2 more
  • N-acetyl cysteine
  • Placebo
  • San Francisco, California
    University of California, San Francisco
Mar 22, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Paris (50 ml blodd sampling)

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • 50 ml blodd sampling
  • Paris, France
    Hôpital La Pitié - Salpêtrière
Aug 16, 2022

Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis
  • 3 mg Melatonin
  • 5 mg Melatonin
  • Portland, Oregon
    Providence MS Center
May 5, 2022

Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic

Recruiting
  • Multiple Sclerosis, Primary Progressive
  • Multiple Sclerosis, Secondary Progressive
  • Magnetic Resonance Imaging
  • +3 more
  • Marseille, France
  • +1 more
Jan 14, 2022

Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

Recruiting
  • Secondary Progressive Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
  • Placebo oral tablet identical to metformin, up to 4 tablets a day
  • Los Angeles, California
    University of California, Los Angeles
May 2, 2022

Systemic Sclerosis, Face, Facial Involvement Trial (Personalized rehabilitation program of facial involvement in systemic

Not yet recruiting
  • Systemic Sclerosis
  • +3 more
  • Personalized rehabilitation program of facial involvement in systemic sclerosis
  • Delivery of a standard prescription for facial rehabilitation
  • (no location specified)
Aug 17, 2022

Multiple Sclerosis Trial in Selçuklu (Yönetebilirim)

Recruiting
  • Multiple Sclerosis
  • Yönetebilirim
  • Selçuklu, Konya, Turkey
    Selcuk University
Jul 4, 2022

5-HT7 Receptor Implication in Inflammatory Mechanisms in

Completed
  • Multiple Sclerosis, Acute Relapsing
  • Multiple Sclerosis
  • blood sampling
  • Orléans, France
    CHR Orléans
Feb 16, 2022

Multiple Sclerosis Fatigue Trial (Ketamine, Midazolam)

Not yet recruiting
  • Multiple Sclerosis Fatigue
  • (no location specified)
May 17, 2022

Experiences of Multiple Sclerosis Patients

Not yet recruiting
  • Multiple Sclerosis
    • (no location specified)
    Aug 12, 2022

    Amyotrophic Lateral Sclerosis Trial (RNS60, Placebo)

    Not yet recruiting
    • Amyotrophic Lateral Sclerosis
    • (no location specified)
    Feb 28, 2022

    Multiple Sclerosis Intimacy and Sexuality Questionnaire

    Completed
    • Multiple Sclerosis
    • +2 more
    • descriptive study
    • Yozgat, Turkey
      Yozgat Bozok University
    May 11, 2022

    Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Ixazomib (NINLARO®) capsules / Matching placebo capsules
    • London, Greater London, United Kingdom
      Royal London Hospital, Barts Health NHS Foundation Trust
    Feb 17, 2022

    Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

    Not yet recruiting
    • Multiple Sclerosis (MS)
    • +6 more
    • Clemastine Fumarate
    • Placebo
    • San Francisco, California
      Sandler Neurosciences Building, Neurological Clinical Research U
    Jul 27, 2022

    Pharmacogenetics of Liver Toxicity in Multiple Sclerosis Treated

    Recruiting
    • Multiple Sclerosis
    • Genetic polymorphism
    • Measurement of fingolimod and fingolimod-phosphate concentrations
    • Caen, France
      Caen University Hospital
    Aug 23, 2022

    Multiple Sclerosis Trial in Istanbul (Reiki)

    Recruiting
    • Multiple Sclerosis
    • Reiki
    • Istanbul, Güneydoğu Anadolu Bölgesi, Turkey
      Istanbul Sabahattin Zaim University, Faculty of Health Sciences
    Jul 12, 2022

    Corrona Multiple Sclerosis (MS) Registry

    Enrolling by invitation
    • Multiple Sclerosis
      • Waltham, Massachusetts
        Corrona, LLC
      Jan 19, 2022

      Multiple Sclerosis Trial in New York (Vancomycin, Placebo)

      Not yet recruiting
      • Multiple Sclerosis
      • New York, New York
        Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mou
      Sep 12, 2022

      Exercise and Pregnancy in People With Multiple Sclerosis

      Recruiting
      • Multiple Sclerosis
      • Pregnancy
      • Moderate-intensity cardiovascular exercise
      • Edmonton, Alberta, Canada
        University of Alberta
      Mar 28, 2022

      Relaxin in Multiple Sclerosis (MS)

      Recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • Blood Draw
      • Lumbar Puncture
      • Portland, Oregon
        Providence MS Center
      Feb 2, 2022

      Multiple Sclerosis, Relapsing-Remitting, Sexual Dysfunction Trial in Birmingham (Behavioural intervention for physical activity

      Active, not recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • Sexual Dysfunction
      • Behavioural intervention for physical activity for multiple sclerosis (BIPAMS)
      • Birmingham, Alabama
        University of Alabama at Birmingham
      May 7, 2022

      Imaging Biomarkers in ALS

      Active, not recruiting
      • Amyotrophic Lateral Sclerosis
      • Primary Lateral Sclerosis
        • Minneapolis, Minnesota
          University of Minnesota
        Mar 11, 2022